Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Clinical trial NCT03217747 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03217747
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Castration-Resistant Prostate Carcinoma Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone Refractory Malignant Solid Neoplasm Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2017-08-02
Primary completion: 2025-09-02
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.